I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Witteveen, P. O
221
results:
Search for persons
X
Format
Online (221)
Mediatypes
Articles (Online) (174)
Bookchapter (Online) (1)
OpenAccess-fulltext (45)
Audio (Online) (1)
Sorted by: Relevance
Sorted by: Year
?
1
Efficacy and safety of durvalumab with olaparib in metastat..:
Post, C.C.B.
;
Westermann, A.M.
;
Boere, I.A.
...
Gynecologic Oncology. 165 (2022) 2 - p. 223-229 , 2022
Link:
https://doi.org/10.1016/..
?
2
Prospective practice survey of management of cetuximab-rela..:
Lugtenberg, R. T.
;
Boers-Doets, C. B.
;
Witteveen, P. O.
...
Supportive Care in Cancer. 29 (2020) 7 - p. 3497-3506 , 2020
Link:
https://doi.org/10.1007/..
?
3
Tamoxifen and pregnancy: an absolute contraindication?:
Schuurman, T. N.
;
Witteveen, P. O.
;
van der Wall, E.
...
Breast Cancer Research and Treatment. 175 (2019) 1 - p. 17-25 , 2019
Link:
https://doi.org/10.1007/..
?
4
Patient-reported outcome measures in a pharmacokinetic stud..:
Koldenhof, J. J.
;
Lankheet, N. A. G.
;
Steeghs, N.
..
Supportive Care in Cancer. 26 (2018) 8 - p. 2641-2650 , 2018
Link:
https://doi.org/10.1007/..
?
5
Interval between debulking surgery and adjuvant chemotherap..:
Timmermans, M.
;
van der Aa, M.A.
;
Lalisang, R.I.
...
Gynecologic Oncology. 150 (2018) 3 - p. 446-450 , 2018
Link:
https://doi.org/10.1016/..
?
6
A phase I, dose escalation, pharmacodynamic, pharmacokineti..:
Milojkovic Kerklaan, B.
;
Slater, S.
;
Flynn, M.
...
Investigational New Drugs. 34 (2016) 3 - p. 329-337 , 2016
Link:
https://doi.org/10.1007/..
?
7
Phase I and pharmacological study of pazopanib in combinati..:
Kerklaan, B Milojkovic
;
Lolkema, M P J
;
Devriese, L A
...
British Journal of Cancer. 113 (2015) 5 - p. 706-715 , 2015
Link:
https://doi.org/10.1038/..
?
8
Symptoms from treatment with sunitinib or sorafenib: a mult..:
Koldenhof, J. J.
;
Witteveen, P. O.
;
de Vos, R.
...
Supportive Care in Cancer. , 2014
Link:
https://doi.org/10.1007/..
?
9
572 Oral panobinostat in patients with advanced tumors and ..:
Porro, M.
;
Sharma, S.
;
Witteveen, P.O.
...
European Journal of Cancer. 50 (2014) - p. 185 , 2014
Link:
https://doi.org/10.1016/..
?
10
Clinical and Radiologic Signs of Relapsed Ovarian Germ Cell..:
Homs, M. Y. V.
;
Schreuder, H. W. R.
;
Jonges, G. N.
.
Case Reports in Obstetrics and Gynecology. 2013 (2013) - p. 1-4 , 2013
Link:
https://doi.org/10.1155/..
?
11
Phase I study of oral CP-4126, a gemcitabine derivative, in..:
Stuurman, F. E.
;
Voest, E. E.
;
Awada, A.
...
Investigational New Drugs. 31 (2013) 4 - p. 959-966 , 2013
Link:
https://doi.org/10.1007/..
?
12
599 Effect of Food On Relative Bioavailability of E7820 in ..:
Slater, S.
;
Witteveen, P.O.
;
Plummer, R.
...
European Journal of Cancer. 48 (2012) - p. 184 , 2012
Link:
https://doi.org/10.1016/..
?
13
Pharmacokinetics of eribulin mesylate in patients with soli..:
Devriese, L. A.
;
Witteveen, P. O.
;
Marchetti, S.
...
Cancer Chemotherapy and Pharmacology. 70 (2012) 6 - p. 823-832 , 2012
Link:
https://doi.org/10.1007/..
?
14
1243 POSTER Eribulin Mesylate Pharmacokinetics in Patients ..:
Devriese, L.
;
Witteveen, P.O.
;
Marchetti, S.
...
European Journal of Cancer. 47 (2011) - p. S157 , 2011
Link:
https://doi.org/10.1016/..
?
15
426 Phase I study of oral CP-4126, a gemcitabine analog, in..:
Stuurman, F.E.
;
Voest, E.E.
;
Awada, A.
...
European Journal of Cancer Supplements. 8 (2010) 7 - p. 135 , 2010
Link:
https://doi.org/10.1016/..
1-15